Related Experiment Videos
Hemoconcentration as an early risk factor for necrotizing pancreatitis
J D Baillargeon1, J Orav, V Ramagopal
1Center for Pancreatic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
The American Journal of Gastroenterology
|November 20, 1998
Summary
Measuring serum hematocrit within 24 hours can help distinguish necrotizing pancreatitis from mild cases. Elevated hematocrit or a lack of decrease at 24 hours are key indicators of severe pancreatic necrosis.
Area of Science:
- Gastroenterology
- Clinical Medicine
- Biochemistry
Background:
- Pancreatitis is a common gastrointestinal condition.
- Distinguishing between mild and necrotizing pancreatitis is crucial for patient management.
- Early identification of severe pancreatitis aids in timely intervention.
Purpose of the Study:
- To evaluate the utility of serum hematocrit measurements in differentiating necrotizing from mild pancreatitis.
- To identify hematocrit-based markers for predicting pancreatic necrosis.
Main Methods:
- A case-control study was conducted between May 1992 and June 1996.
- Patients with necrotizing pancreatitis were compared to those with mild pancreatitis.
- Serum hematocrit levels were measured at admission and at 24 hours.
Main Results:
- Logistic regression identified admission hematocrit ≥47% and failure to decrease at 24 hours as significant risk factors for necrotizing pancreatitis.
- At admission, 34% sensitivity and 91% specificity were observed for hematocrit ≥47%.
- At 24 hours, sensitivity increased to 81% and specificity to 88% when considering hematocrit changes.
Conclusions:
- Hemoconcentration, indicated by admission hematocrit ≥47% or no decrease at 24 hours, strongly predicts pancreatic necrosis.
- Serum hematocrit monitoring provides valuable insights into pancreatitis severity.
- These findings support the use of hematocrit as an early diagnostic marker for severe pancreatitis.